Discussion with Investigators of Implications of these Stage II and III Trials on Surgical De-escalation and Tailored Adjuvant Treatment

Faculty(s)

• 

  Alexander C.J van Akkooi, MD, PhD, MSc, FRACS (he/him/his)

  Surgical Oncologist
  Melanoma Institute of Australia
  Sydney, New South Wales, Australia
• GK

  Giorgos C. Karakousis, MD (he/him/his)

  Professor of Surgery
  Department of Surgery, University of Pennsylvania Health System, United States